Estradiol (E2) acts on skin via estrogen receptors, stimulating collagen production, hyaluronic acid synthesis, and vascularization. Fact: Declining E2 after menopause correlates with thinner skin, increased wrinkling, and dryness. Myth: Topical estradiol is a safe fountain of youth. Evidence shows that unmonitored use can lead to systemic absorption and risks (e.g., endometrial stimulation). Most data come from mechanistic and observational studies; robust clinical trials on cosmetic anti-aging are lacking. Some products claim 'plant-based estrogens' work like estradiol – but efficacy and safety are poorly supported. Conclusion: Estradiol has real dermatological effects, but marketing often exaggerates. For medical indications (e.g., vulvovaginal atrophy), low-dose topical estradiol is evidence-based. For general skin rejuvenation, the risk-benefit ratio is unclear. Always consult a physician before using hormone-containing skincare.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-607dcabab48bc7520a8427a0